KCT0004717
Completed
未知
A Study for Discovering Biomarker Candidates of Idiopathic Parkinson's Disease - A Pilot Study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gachon University Gil Medical Center
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Parkinson's disease (experimental group)
- •\-Those who have not been diagnosed with dementia among Parkinson's disease outpatients of Gil Medical Center Neurology
- •\-Criteria of UK Parkinson's Diseases Society Brain Bank Criteria
- •\-40 years old and over, total 15 people
- •2\) Control group
- •\-Have no family history of movement disorder
- •\-Persons who do not meet other exclusion criteria
- •\-40 years old and over, total 15 people
Exclusion Criteria
- •1\) The following people are excluded from the experimental group
- •Pregnant women
- •Women who are currently breastfeeding
- •Patients with poor condition that are difficult to perform the test
- •Patients with brain diseases other than Parkinsonism
- •Persons deemed inappropriate by the clinical researcher in addition to the above items.
- •2\) The following people are excluded from the control group.
- •Pregnant women
- •Women who are currently breastfeeding
- •Staff or students in the same institution
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Biomarker signature discovery study to determine acute bacterial respiratory tract infection.NL-OMON56538evels Diagnostics300
Completed
Not Applicable
Biomarker study; study to identify biomarkers for protein intake, a randomized, fully controlled feeding studyGeen aandoeningenUitscheiding van biomerkers na het eten van eiwit in het gezond menselijk lichaamBiomarkers of protein intakeNL-OMON36525Wageningen Universiteit25
Completed
Phase 2
Biomarker discovery study to identify patients with advanced urothelial cancer benefitting from pembrolizumab treatmenturinary tract cancerurothelial carcinoma10038364NL-OMON53077Erasmus MC, Universitair Medisch Centrum Rotterdam80
Active, not recruiting
Phase 1
Biomarker discovery study to identify patients with advanced urothelial cancer benefitting from pembrolizumab treatmentEUCTR2017-000976-27-NLErasmus MC Cancer Institute80
Recruiting
Not Applicable
Discovery of Novel Biomarkers for the Diagnosis of TB DiseaseA15Respiratory tuberculosis, bacteriologically and histologically confirmedDRKS00032445Roche360